AIAISci
中文
clinical updateBiotech

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Clinical/translation signal: PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

Occurred SourceClinicalTrials.govapprovedSourceClinicalTrials.gov

Factual summary

What happened

ClinicalTrials.gov registry update for PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

SourceClinicalTrials.gov

Why it matters

Clinical trial registry updates are translation signals, not commercialization claims by themselves.

SourceClinicalTrials.gov

Limitations

ClinicalTrials.gov status does not prove product approval, licensing, revenue, or market adoption.

SourceClinicalTrials.gov

Linked output

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survivalclinical trial

People

No reviewed person relationship is attached to this event.

Organizations

UNC Lineberger Comprehensive Cancer Center

Topics

No reviewed topic relationship is attached to this event.

Problems

No reviewed problem relationship is attached to this event.

Relationship evidence

Timeline

  1. clinical updatePROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
    SourceClinicalTrials.gov